Pharvaris (PHVS) Net Income towards Common Stockholders (2020 - 2026)

Pharvaris (PHVS) has 7 years of Net Income towards Common Stockholders data on file, last reported at -$45.8 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 6.35% year-over-year to -$45.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$91.4 million (up 8.54% YoY) and the FY2025 annual result came in at -$198.5 million, down 36.64% from the prior year.
• Net Income towards Common Stockholders rose to -$45.8 million in Q1 2026, from -$53.9 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $51.8 million in Q2 2025 to a low of -$53.9 million in Q4 2025.
• A 5-year average of -$19.8 million and a median of -$30.4 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders surged 174.08% — and 2023, when it tumbled 207.77%.
• Tracing PHVS's Net Income towards Common Stockholders over 5 years: stood at -$40.1 million in 2022, then rose by 12.26% to -$35.2 million in 2023, then retreated by 5.39% to -$37.1 million in 2024, then slumped by 45.4% to -$53.9 million in 2025, then climbed by 15.14% to -$45.8 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$45.8 million (Q1 2026), -$53.9 million (Q4 2025), and -$43.4 million (Q3 2025), per Business Quant data.